Guanfacine 46708-0747-91
- Manufacturer
- Alembic Pharmaceuticals Limited
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 8, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA217269
Need to source Guanfacine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guanfacine Hydrochloride | 3 mg/1 |
Drug Class
Adrenergic alpha2-Agonists [MoA]Central alpha-2 Adrenergic Agonist [EPC]
Selected Package
46708-0747-91Selected1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-747-91)
Other packages for this product(1)
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-747-31)